1 enrolling by invitation. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow ribociclib: new trials by email Literature Review of ribociclib trials Research Report on ribociclib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| T-DM1 Combined With CDK4/6 Inhibitor Ribociclib Ribociclib Oral Tablet - HER2-positive Advanced Breast Cancer | Phase 2 | Enrolling by invitation | Zheng Yabing | 40 | 2023-10-25 | 2024-07-01 |
Zheng Yabing (1)
China (1)
Yabing Zheng, MD (1)